Cargando…
Innovative research methods for studying treatments for rare diseases: methodological review
Objective To examine methods for generating evidence on health outcomes in patients with rare diseases. Design Methodological review of existing literature. Setting PubMed, Embase, and Academic Search Premier searched for articles describing innovative approaches to randomized trial design and analy...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242670/ https://www.ncbi.nlm.nih.gov/pubmed/25422272 http://dx.doi.org/10.1136/bmj.g6802 |
_version_ | 1782345987603300352 |
---|---|
author | Gagne, Joshua J Thompson, Lauren O’Keefe, Kelly Kesselheim, Aaron S |
author_facet | Gagne, Joshua J Thompson, Lauren O’Keefe, Kelly Kesselheim, Aaron S |
author_sort | Gagne, Joshua J |
collection | PubMed |
description | Objective To examine methods for generating evidence on health outcomes in patients with rare diseases. Design Methodological review of existing literature. Setting PubMed, Embase, and Academic Search Premier searched for articles describing innovative approaches to randomized trial design and analysis methods and methods for conducting observational research in patients with rare diseases. Main outcome measures We assessed information related to the proposed methods, the specific rare disease being studied, and outcomes from the application of the methods. We summarize methods with respect to their advantages in studying health outcomes in rare diseases and provide examples of their application. Results We identified 46 articles that proposed or described methods for studying patient health outcomes in rare diseases. Articles covered a wide range of rare diseases and most (72%) were published in 2008 or later. We identified 16 research strategies for studying rare disease. Innovative clinical trial methods minimize sample size requirements (n=4) and maximize the proportion of patients who receive active treatment (n=2), strategies crucial to studying small populations of patients with limited treatment choices. No studies describing unique methods for conducting observational studies in patients with rare diseases were identified. Conclusions Though numerous studies apply unique clinical trial designs and considerations to assess patient health outcomes in rare diseases, less attention has been paid to innovative methods for studying rare diseases using observational data. |
format | Online Article Text |
id | pubmed-4242670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-42426702014-12-04 Innovative research methods for studying treatments for rare diseases: methodological review Gagne, Joshua J Thompson, Lauren O’Keefe, Kelly Kesselheim, Aaron S BMJ Research Objective To examine methods for generating evidence on health outcomes in patients with rare diseases. Design Methodological review of existing literature. Setting PubMed, Embase, and Academic Search Premier searched for articles describing innovative approaches to randomized trial design and analysis methods and methods for conducting observational research in patients with rare diseases. Main outcome measures We assessed information related to the proposed methods, the specific rare disease being studied, and outcomes from the application of the methods. We summarize methods with respect to their advantages in studying health outcomes in rare diseases and provide examples of their application. Results We identified 46 articles that proposed or described methods for studying patient health outcomes in rare diseases. Articles covered a wide range of rare diseases and most (72%) were published in 2008 or later. We identified 16 research strategies for studying rare disease. Innovative clinical trial methods minimize sample size requirements (n=4) and maximize the proportion of patients who receive active treatment (n=2), strategies crucial to studying small populations of patients with limited treatment choices. No studies describing unique methods for conducting observational studies in patients with rare diseases were identified. Conclusions Though numerous studies apply unique clinical trial designs and considerations to assess patient health outcomes in rare diseases, less attention has been paid to innovative methods for studying rare diseases using observational data. BMJ Publishing Group Ltd. 2014-11-24 /pmc/articles/PMC4242670/ /pubmed/25422272 http://dx.doi.org/10.1136/bmj.g6802 Text en © Gagne et al 2014 http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Research Gagne, Joshua J Thompson, Lauren O’Keefe, Kelly Kesselheim, Aaron S Innovative research methods for studying treatments for rare diseases: methodological review |
title | Innovative research methods for studying treatments for rare diseases: methodological review |
title_full | Innovative research methods for studying treatments for rare diseases: methodological review |
title_fullStr | Innovative research methods for studying treatments for rare diseases: methodological review |
title_full_unstemmed | Innovative research methods for studying treatments for rare diseases: methodological review |
title_short | Innovative research methods for studying treatments for rare diseases: methodological review |
title_sort | innovative research methods for studying treatments for rare diseases: methodological review |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4242670/ https://www.ncbi.nlm.nih.gov/pubmed/25422272 http://dx.doi.org/10.1136/bmj.g6802 |
work_keys_str_mv | AT gagnejoshuaj innovativeresearchmethodsforstudyingtreatmentsforrarediseasesmethodologicalreview AT thompsonlauren innovativeresearchmethodsforstudyingtreatmentsforrarediseasesmethodologicalreview AT okeefekelly innovativeresearchmethodsforstudyingtreatmentsforrarediseasesmethodologicalreview AT kesselheimaarons innovativeresearchmethodsforstudyingtreatmentsforrarediseasesmethodologicalreview |